A commentary on Marcotte, T. D. et al. Driving Performance and Cannabis Users’ Perception of Safety. JAMA Psychiatry 79, 1–9 (2022). Phil Molloy, MD, is a contributor to this blog post. Be sure to check out our journal club discussion on this topic under live events at https://www.prc-trials-plus.com.

A commentary on Uthayakumaran, K., Sunil, M. & Ratcliffe, E. M. Evaluating the Role of the Endocannabinoid System in Axon Guidance: A Literature Review. Cannabis Cannabinoid Res.(2024) doi:10.1089/can.2023.0138

An update for clinical audiences and health care professionals on recent media coverage regarding psychosis and cannabis (2024).

Cannabis is part of a revolution, often referred to as the 4th industrial revolution or industry 4.0, which has at its center, a food revolution.

This a trancript of opening remarks from an ASTM symposium covering contaminants in cannabis (aka hemp) plants.

(3 min read) A commentary on a Wall Street Journal article covering the cannabis and psychosis debate.

The field of cannabis research is often perceived as dynamic andThis year’s review includes a statistical roundup of intriguing data, selected quotes from various publications, an evaluation of the most notable and lackluster research paper titles, and a reflection on some of the projects I found particularly rewarding.

A book review about a text that focuses on botany and biotechnology, authored by a diverse array cannabis experts.

(2 min read) The molecular mechanisms that may underpin the effects of CBD on skin cells.

Just a dab of science! - This is a short, 300 word article discussing an animal model of endometriosis.

Stress, an ever-persistent element in modern life, significantly impacts our mental health. But what if there was a natural remedy that could help mitigate these effects? Recent research delves into how CBD might just be that solution, especially for those at high risk for psychosis.

“A single plasma AEA or PEA measurement can predict PTB. A single AEA measurement predicts the gestational age of delivery and the remaining period of pregnancy with reasonable accuracy and better than existing conventional tests thus offering a better window for primary prevention of PTB.”

(7 minute read) This article discusses research on cannabis, eye health, vision, visual processing, driving, and fishing at night.

Dr. Yasmin Hurd, known for her work on CBD and opioid withdrawal at Mt. Sinai in New York, recently stated in an article, “Another critical path toward greater evidenced-based research is the collaboration between legitimate companies and researchers that is important for developing appropriate medicinal formulations and routes of administration best suited for targeted medical indications.”

Researchers in Italy discovered that truffles, also known as “the diamond of the kitchen,” produce the endocannabinoid called anandamide. The presence of anandamide in fungi suggests that the proteins that make endcannabinoids evolved before the cannabinoid (CB) receptor.

Treatments for opioid dependence with drugs such as methadone or conventional medications run the risk of making the patient addicted or dependent on the medication. Conventional treatments for opiate dependence can induce severe withdrawal symptoms if the medication is stopped abruptly. A great need remains for the development of non-opioid drug therapies that have less dependence and abuse liability.

The increasing abuse of Percocet and other opiate drugs is also leading to an increase in heroin use, and skyrocketing amount of people seeking treatment for opiate dependence. Cannabis seems to be a significant factor in opioid use.

(3 min read) The International Association for Cannabinoid Medicine published a bulletin highlighting the preliminary results from an observational clinical trial studying the effects of Cannabis on post traumatic stress disorder (PTSD).

(2 min read) A commentary on the role of vitamin E and cannabinoid receptors.

(3 min read) Coverage of the 2011 International Cannabinoid Research Society meeting in Illinois.